Symptom explainers

Every US Pfizer/Moderna preferred term with a ≥ 30 through Dec 2022 (~4,200 rows — one per symptom × brand). Cumulative scores through 2022-12; links open the explainer at that month. Scores and reports are stored as parquet and loaded in the browser.

Column legend
Reports (a)
Observed count of this preferred term for the brand through the month (cumulative).
E (MGPS)
Age/sex-stratified expected count under MGPS (Mantel–Haenszel).
E (RGPS)
Regression-adjusted expected count under RGPS (accounts for product masking).
PRR
Proportional Reporting Ratio — unstratified [a/(a+b)] / [c/(c+d)].
EBGM
MGPS score: Empirical Bayes Geometric Mean of a / E(MGPS) after shrinkage.
EB05
5th percentile of the MGPS posterior (lower credible bound for EBGM).
ERAM
RGPS score: Empirical Bayes Arithmetic Mean of a / E(RGPS) after shrinkage.
ER05
5th percentile of the RGPS posterior (lower credible bound for ERAM).
Masking
How much RGPS raises the score over MGPS: ERAM/EBGM − 1 (shown as %).
Predictors
Number of other vaccine products selected as RGPS masking predictors for this PT.

Full walkthrough: MGPS vs RGPS.

Loading catalog-2022-12.parquet…